We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
-7.45%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$549M
AUM Growth
-$91.5M
Cap. Flow
+$1.02M
Cap. Flow %
0.19%
Top 10 Hldgs %
42.34%
Holding
105
New
18
Increased
27
Reduced
20
Closed
23

Top Buys

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$9.69M
2
CYTK icon
Cytokinetics
CYTK
+$7.79M
3
AMD icon
Advanced Micro Devices
AMD
+$5.25M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$4.87M
5
PMN icon
ProMIS Neurosciences
PMN
+$4.77M

Top Sells

Rank Stock Value
1
NICE icon
Nice
NICE
+$9.95M
2
NVMI
Nova
NVMI
+$8.21M
3
CAMT icon
Camtek
CAMT
+$6.75M
4
SAGE
Sage Therapeutics
SAGE
+$6.02M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$5.29M

Sector Composition

Rank Sector Weight
1 Healthcare 60.67%
2 Miscellaneous 27.99%
3 Technology 7.83%
4 Consumer Discretionary 2.21%
5 Communication Services 0.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAC icon
76
Cartesian Therapeutics
RNAC
$239M
$797K 0.15%
25,071
-42,879
-63% -$1.43M
APGE
77
DELISTED
Apogee Therapeutics
APGE
$639K 0.12%
+30,000
New +$661K
ELEV
78
DELISTED
Elevation Oncology
ELEV
$596K 0.11%
900,000
– –
VTGN icon
79
VistaGen Therapeutics
VTGN
$10.4M
$524K 0.1%
+100,000
New +$444K
IMTXW
80
DELISTED
Immatics N.V. Warrants
IMTXW
$354K 0.06%
100,000
– –
CALT
81
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$217K 0.04%
+11,863
New +$205K
ACLX
82
DELISTED
Arcellx
ACLX
– –
-77,488
Closed -$2.45M
ALT icon
83
Altimmune
ALT
$628M
– –
-500,000
Closed -$1.76M
AMD icon
84
CALL
Advanced Micro Devices
AMD
$890B
– –
-120,000
Closed -$13.7M
ARBE icon
85
Arbe Robotics
ARBE
$86.6M
– –
-43,165
Closed -$125K
ARGX icon
86
PUT
argenx
ARGX
$62B
– –
-10,000
Closed -$3.9M
BBIO icon
87
CALL
BridgeBio Pharma
BBIO
$13.2B
– –
-130,000
Closed -$2.24M
CAMT icon
88
Camtek
CAMT
$6.8B
– –
-189,494
Closed -$6.75M
BGMS
89
Bio Green Med Solution Inc
BGMS
$6.11M
– –
-69
Closed -$147K
DYN icon
90
Dyne Therapeutics
DYN
$3.34B
– –
-119,918
Closed -$1.35M
ENLT icon
91
Enlight Renewable Energy
ENLT
$10.5B
– –
-211,586
Closed -$3.76M
ENPH icon
92
CALL
Enphase Energy
ENPH
$4.8B
– –
-40,000
Closed -$6.7M
GNRC icon
93
CALL
Generac Holdings
GNRC
$12.2B
– –
-52,500
Closed -$7.83M
MRSN
94
DELISTED
Mersana Therapeutics
MRSN
– –
-16,742
Closed -$1.38M
MSFT icon
95
CALL
Microsoft
MSFT
$3.68T
– –
-21,000
Closed -$7.15M
NVMI
96
Nova
NVMI
$11B
– –
-70,000
Closed -$8.21M
PMVP icon
97
PMV Pharmaceuticals
PMVP
$77.5M
– –
-187,800
Closed -$1.18M
QCOM icon
98
Qualcomm
QCOM
$203B
– –
-32,000
Closed -$3.81M
SAGE
99
DELISTED
Sage Therapeutics
SAGE
– –
-128,000
Closed -$6.02M
SRPT icon
100
CALL
Sarepta Therapeutics
SRPT
$2.19B
– –
-78,300
Closed -$8.97M
1 2 3
4
5

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sphera Funds Management held 105 positions worth $549M, down 14% from $640M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sphera Funds Management's Q3 2023 filing shows 18 new, 27 increased, 20 reduced and 23 closed positions. Its largest new stake was Cytokinetics: 233,933 shares worth $6.89M. The largest sale was Nice, an estimated $9.95M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 57% a quarter earlier, followed by Miscellaneous and Technology.

  • Sphera Funds Management's largest Q3 2023 buy was Cytokinetics: 233,933 shares worth $6.89M.
  • Sphera Funds Management added most to Tower Semiconductor in Q3 2023, an estimated $9.69M increase.
  • Sphera Funds Management's biggest Q3 2023 reduction was Nice, cutting an estimated $9.95M.
  • Sphera Funds Management fully exited Nova in Q3 2023, selling an estimated $8.21M.
  • Sphera Funds Management's ten largest holdings make up 42% of its $549M portfolio in Q3 2023.
  • Sphera Funds Management opened 18 new positions and closed 23 in Q3 2023.
  • Sphera Funds Management's portfolio value fell 14% quarter-over-quarter to $549M.

Based on Sphera Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.